Clinical Trial Update: Tailored Versus Coventional AntiPlaTelet Strategy Intended After OPTIMIZEd Drug Eluting Stent [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating tailored versus conventional antiplatelet strategies after an optimized drug-eluting stent; the study is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Asan Medical Center | Conditions: Coronary Artery Disease | Phase 4 | Status: RECRUITING